Sequence-dependent effect of docetaxel and gefitinib on the proliferation of human lung adenocarcinoma cell lines PC-9

汤乃望,陈智伟

DOI: https://doi.org/10.3969/j.issn.1671-7562.2014.04.001

2014-01-01

Abstract:Objective: To observe the effect of sequential administration of gefitinib and docetaxel on lung adenocarcinoma cell line containing mutation of epidermal growth factor receptor( EGFR),and to get the best drug combination patterns. Methods: PC-9 cell line was used for research,which was a EGFR mutation cell line of the human lung adenocarcinoma with deletion in exon 19. Administration in different sequence or combination with gefitinib and docetaxel on PC-9 cell line was to understand the sequence-dependent effect well,through analysing the inhibition of PC-9 cell lines with CCK8 assay,studying the apoptosis by FCM,and detecting the protein expressions of phosphorylated EGFR( pEGFR),phosphorylated Akt( pAkt) by Western blot. Results: The content of Sub-G1 DNA in group of sequential administration of docetaxel 24 hours following gefitinib 48 hours was most obvious among each experimental groups. It was 34% ± 2%. There was statistical difference between group of sequential administration of docetaxel 24 hours following gefitinib 48 hours and docetaxel 72 hours,P 0. 05. There was synergistic effect in this pattern. Simultaneously,the signalling pathways of pEGFR and pAkt were inhibited when apoptosis of PC-9 cells was happening. Conclusion: The best mode of administration to control the growth of EGFR mutational cell lines,PC-9,is docetaxel following gefitinib.